The global bioreactor and fermenter market size was estimated to be US$ 2.3 billion in 2020 and is expected to reach US$ 8.2 billion by 2031 at a CAGR of 12.2%.
Bioreactors, or enormous fermenters, are ordinarily used in the biopharmaceutical field to deliver biologics for a large extent, like vaccination serums, recombinant proteins, and monoclonal antibodies.
In April 2018, Sartorius Ste dim Biotech along with Pennsylvania State University (US) approved an agreement, wherein Sartorius would put resources into the fermentation facility and a lab to upgrade the fermentation facility in Penn State’s Center of Excellence in Industrial Biotechnology (CoEIB) situated in the United States of America. Since the previous few years, the huge scope of bio-fabricating has gotten more pragmatic, resulting from progressions in techniques and the simple accessibility of machines sufficiently enormous to create high volumes of biologics because of progress in medical and health care systems worldwide.
These progressions have supported the necessity for mechanism, as demand for small volume and multi-specialty features have empowered offices to change unit activities dependent on request, as a result curbing the wastage and extra costs required. Besides, flooding demand for customized medications combined with rising number of FDA supported medications has prompted expanded bio creation, which thus is postulated to offer significant possibilities for the business development in the coming years. The biopharmaceutical organizations segment is relied upon to contribute to the worldwide bioreactors and fermenters market income share during the forecast time frame.
This would require a degree of adaptability and speed in development, which is absurd with regular bioreactors. Demand for single-use bioreactors is postulated to additional ascent as cost pressures from the medical services suppliers increase and new business sectors open. Subsequently, the rising Research and development use is considered a positive marker of the extension of the bioreactors and fermenters market during 2022-2032. North America and Europe directed a reasonable predominance in the worldwide bioreactors and fermenters market during 2020.
Global Bioreactor and Fermenter Market Value Share Analysis, by Geography (2021)
The report titled “Global Bioreactor and Fermenter Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032”, wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Global Bioreactor and Fermenter Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global Bioreactor and Fermenter market is segmented based on Type, Process, End user, and region. Based on Type, the Bioreactor and Fermenter market is segmented into single-use bioreactors, multiple-use bioreactors, and others. Based on Process type, the Bioreactor and Fermenter market is segmented into fed batch, continuous, batch, and others. Based on End user type, the Bioreactor and Fermenter market is segmented into biopharmaceutical companies, CROs, academic & research institutes, and others.
Based on geography, the Global Bioreactor and Fermenter Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada, and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Italy, France, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Global Bioreactor and Fermenter Market. Further, market share of prominent companies in the Global Bioreactor and Fermenter Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Bioreactor and Fermenter companies. The Global Bioreactor and Fermenter Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Bioreactor and Fermenter business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the Global Bioreactor and Fermenter Market.
The key players of the Global Bioreactor and Fermenter Market are Danaher Corporation, Applikon Biotechnology B.V., PBS Biotech, Inc., Finesse Solutions, Inc., Sartorius AG, PIERRE GUERIN TECHNOLOGIES, Eppendorf AG, ZETA Holding GmbH, GE Healthcare, Solaris Biotechnology srl, Thermo Fisher Scientific Inc, Merck KGaA and others.
Global Bioreactor and Fermenter Market Key Segments:
Based on Type
Based on Process
Based on End user
The global Bioreactor and Fermenter market was worth US$ 8.2 billion in 2020.
The global market for Bioreactor and Fermenter will most likely expand at over 12.2% CAGR through 2032.
Key Bioreactor and Fermenter market players are Danaher Corporation, Applikon Biotechnology B.V., PBS Biotech, Inc., Finesse Solutions, Inc., Sartorius AG, PIERRE GUERIN TECHNOLOGIES, Eppendorf AG, ZETA Holding GmbH and others.
Based on type, the Bioreactor and Fermenter market is segmented into Single-use bioreactors and Multiple-use bioreactors.
North America is the principal contributor to the global Bioreactor and Fermenter market.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved